Posillico J T, Wortsman J, Srikanta S, Eisenbarth G S, Mallette L E, Brown E M
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
J Bone Miner Res. 1986 Oct;1(5):475-83. doi: 10.1002/jbmr.5650010512.
Serum autoantibodies directed toward antigenic determinants on the surface of human parathyroid cells (PTAb-CS) have been demonstrated in a subset (8 of 23) of adult patients with idiopathic hypoparathyroidism (IHP). In sera from 3 of 8 patients with PTAb-CS, binding of these autoantibodies to their respective parathyroid cell surface antigen(s) resulted in marked inhibition of parathyroid hormone (PTH) secretion in an in vitro dispersed human parathyroid cell (dPTC) system. In 1 subject evaluated longitudinally, circulating levels of PTAb-CS, and the magnitude of the inhibitory effect on PTH secretion, temporally correlated with the clinical course of the hypoparathyroidism. These findings suggest a causative role for antibodies directed against cell surface antigens in parathyroid dysfunction in some cases of "autoimmune" hypoparathyroidism.
在一部分(23例中的8例)成年特发性甲状旁腺功能减退症(IHP)患者中,已证实存在针对人甲状旁腺细胞表面抗原决定簇的血清自身抗体(PTAb-CS)。在8例有PTAb-CS的患者中,有3例患者血清中的这些自身抗体与其各自的甲状旁腺细胞表面抗原结合,在体外分散的人甲状旁腺细胞(dPTC)系统中导致甲状旁腺激素(PTH)分泌受到显著抑制。在1例接受纵向评估的受试者中,PTAb-CS的循环水平以及对PTH分泌的抑制作用强度与甲状旁腺功能减退症的临床病程在时间上相关。这些发现提示,在某些“自身免疫性”甲状旁腺功能减退症病例中,针对细胞表面抗原的抗体在甲状旁腺功能障碍中起致病作用。